RxDoctor Payments Data

Kristyn Sola

Physician Assistant · Miami, FLNPI 1417583949

Payments from drug & device makers

$5,117in general payments, 2019–2025

Across 234 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$907
  • Phathom Pharmaceuticals, Inc.$391
  • Takeda Pharmaceuticals U.S.A., Inc.$265
  • Lilly USA, LLC$256
  • Ardelyx, Inc.$177
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$5,04199%
  • Education$761%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,117 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$31,255
Medicare patients
228
Services billed
322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClenpiqSod Picosulf/Mag Ox/Citric Ac128$21,969
LinzessLinaclotide16$11,766
SutabSod Sulf/Pot Chloride/Mag Sulf22$3,563
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates39$2,681
SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag11$1,375
Ursodiol13$1,262
Omeprazole68$1,172
Famotidine74$1,110
Pantoprazole Sodium70$658
Dicyclomine Hcl18$485
Sucralfate16$414
Esomeprazole Magnesium15$406
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl15$249
Hydrocortisone15$197
Carvedilol14$78

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,720$11,76616 claims
Braintree Laboratories, Inc.Sutab, Suflave$28$4,93833 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →